| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 04/19/2001 | WO2001026670A1 Skin-care agents, skin antiaging agents, whitening agents and external skin preparations |
| 04/19/2001 | WO2001026656A2 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | DE19947373A1 Combination preparation comprising tocopherol and magnesium ascorbate for treatment and prevention of conditions resulting from oxidative stress |
| 04/19/2001 | CA2399093A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 04/19/2001 | CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine |
| 04/19/2001 | CA2387545A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | CA2387184A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | CA2385139A1 Skin-beautifying agent, anti-aging agent for the skin, whitening agent and external agent for the skin |
| 04/19/2001 | CA2382605A1 Pyrimidine derivatives |
| 04/18/2001 | EP1092765A2 Germination-activated red Ganoderma lucidum spores and method for producing the same |
| 04/18/2001 | EP1091966A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 04/18/2001 | CN1291468A Condensed benzene derivative used as antioxidant or free radical scavenger and its use in cosmetic preparations |
| 04/17/2001 | US6218432 Diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them |
| 04/17/2001 | US6218423 Administering pyrrolidine derivative for therapy of nerve-related vision disorder, improving vision, treating memory impairment, or enhancing memory performance in animal |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218384 3-Oxo-pyrido(1,2-a)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders |
| 04/17/2001 | US6217893 Sustained-release compositions and method for preparing same |
| 04/17/2001 | US6217889 Personal care articles |
| 04/17/2001 | US6217859 Orally administering genetic engineered bacteria |
| 04/12/2001 | WO2001024795A1 RETARD FORM CONTAINING α-LIPOIC ACID (DERIVATIVES) |
| 04/12/2001 | WO2001024793A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2001 | CA2386461A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/11/2001 | EP1089740A1 TREATMENT OF $i(C. DIFFICILE) TOXIN B ASSOCIATED CONDITIONS |
| 04/11/2001 | EP1089728A1 Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |
| 04/11/2001 | CN1291184A Cycloalkene derivatives, process for producing the same and use |
| 04/10/2001 | US6214844 Substituted imidazole compounds |
| 04/10/2001 | US6214817 Nitrogen macrocycle complexes with manganese and iron |
| 04/10/2001 | CA2180487C Water for medical treatment, production method thereof, and dialysis apparatus using water for medical treatment as dialysis liquid |
| 04/05/2001 | WO2001023408A1 5-hydroxysapogenin derivatives with anti-dementia activity |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001022937A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | WO2001008657A3 Personal care articles |
| 04/05/2001 | WO2000072867A3 Substantially oil-free cyclosporin compositions |
| 04/05/2001 | WO2000032805A9 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases |
| 04/05/2001 | CA2385989A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | CA2385169A1 43 human secreted proteins |
| 04/04/2001 | EP1088890A2 Recombinant BPI proteins, uses of BPI proteins, and methods of preparing same |
| 04/04/2001 | EP1087776A1 A process for the treatment of organophosphate poisoning |
| 04/04/2001 | EP1087768A1 Use of 1-(aminoalkyl)-3-quinoxaline-2-one derivatives for the preparation of compounds having an antioxidant action |
| 04/04/2001 | CN1063968C Candy without sugar and for reducing toxic effect of cigarette |
| 04/03/2001 | US6211243 Methods for treating cold sores with anti-infective compositions |
| 03/29/2001 | WO2001021812A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | WO2001021575A1 Anti-inflammatory nitro- and thia- fatty acids |
| 03/29/2001 | WO2001021172A1 Anti-cancer nitro- and thia-fatty acids |
| 03/29/2001 | WO2001021171A1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 03/29/2001 | WO2001021170A1 Systems for delivering anti-infective compositions from frangible ampules to treat disordered tissue such as cold sores |
| 03/29/2001 | WO2001020981A2 Anti-infective compositions for treating disordered tissue such as cold sores |
| 03/29/2001 | CA2385552A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | CA2384829A1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 03/28/2001 | EP1086693A1 Compositions containing proanthocyanidin and a vitamin B6 derivative or a salt thereof |
| 03/28/2001 | CN1288688A Composition containing original flower pigment and vitamin B6 derivative or its salt |
| 03/27/2001 | US6207685 Inhibiting effects of exogenous neurotoxic or neurotoxinic products in warm-blooded animals by administering 2-methyl-1-(1-piperidinyl)-1-(2-thienyl)-cyclohexane in pure racemic, diastereoisomeric or enantiomeric form |
| 03/22/2001 | WO2001019823A2 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 03/22/2001 | WO2001019397A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | WO2001019377A1 Oenothein medicaments |
| 03/22/2001 | WO2001019360A2 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 03/22/2001 | WO2001019158A2 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 03/22/2001 | WO2000059899A8 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| 03/22/2001 | CA2384733A1 Methods and compositions utilizing rad51 |
| 03/21/2001 | CN1287859A Traditional Chinese medicinal pill for removing blood stasis |
| 03/21/2001 | CN1063444C Stable crystalline (65)-and (GR)-tetrahydrofolic acid |
| 03/21/2001 | CA2319967A1 Compositions containing proanthocyanidin and a vitamin b6 derivative or a salt thereof |
| 03/15/2001 | WO2001018038A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/15/2001 | WO2001018033A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | WO2001018011A1 Calcium complex of phosphorus containing ethylenediamine derivatives |
| 03/15/2001 | WO2001017978A1 Tetrahydrobenzotriazine derivatives |
| 03/15/2001 | WO2001017530A1 Iron chelators and uses thereof |
| 03/15/2001 | WO2001017519A1 Sunscreen agent for oral administration |
| 03/15/2001 | WO2001017495A1 Skincare composition against free radicals |
| 03/15/2001 | DE19942774A1 Zubereitungen zur oralen Aufnahme Preparations for oral administration |
| 03/15/2001 | DE19941217A1 Behandlung der Migräne durch Verabreichung von alpha-Liponsäure oder Derivaten derselben Treatment of migraine by administration of alpha-lipoic acid or derivatives thereof |
| 03/15/2001 | CA2386555A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | CA2383721A1 Use of 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogues as iron chelators |
| 03/15/2001 | CA2379532A1 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/14/2001 | EP1083172A1 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 03/14/2001 | EP1082005A1 Coenzyme q10 compositions for organ protection during perfusion |
| 03/14/2001 | EP0682664B1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 03/13/2001 | US6200962 As antioxidants for therapy and prophylaxis oxidative damage which is believed to be involved in development of human disorders i.e., atherosclerosis, cancer, rheumatoid artritis |
| 03/10/2001 | CA2282185A1 Oenothein medicaments |
| 03/08/2001 | WO2001016134A1 Selective antagonists of a2b adenosine receptors |
| 03/08/2001 | WO2001015716A1 Plant extract mixtures and their uses |
| 03/08/2001 | WO2001015693A2 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 03/08/2001 | WO2001015663A1 Purifying and/or regenerating agent |
| 03/08/2001 | WO2000059448A3 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 03/08/2001 | DE19941595A1 Verwendung von anellierten Benzolderivaten als Antioxidans oder Radikalfänger in kosmetischen Zubereitungen Use of fused benzene derivatives as antioxidant or free radical scavengers in cosmetic preparations |
| 03/08/2001 | CA2382551A1 Plant extract mixtures and their uses |
| 03/07/2001 | EP1080726A1 Agents for relieving side effects |
| 03/07/2001 | EP1080716A1 Annelated benzene derivatives as antioxidants and radical scavengers in cosmetic preparations |
| 03/07/2001 | EP1079832A1 Use of vitamin pp compounds |
| 03/07/2001 | CN1062734C Immunopotentiator for treating disease caused by toxic reaction of excessive free radicals |
| 03/06/2001 | US6197825 Azulenyl nitrone spin trapping agents, methods of making and using same |
| 03/06/2001 | US6197786 Anticholesterol agents |
| 03/06/2001 | US6197745 Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
| 03/06/2001 | US6197333 Materials and methods for making improved liposome compositions |
| 03/01/2001 | WO2001013939A1 High density lipoprotein against organ dysfunction following haemorrhagic shock |
| 03/01/2001 | DE19941360A1 Entschlackungs- und/oder Regenerationsmittel Purification and / or regenerating agent |
| 02/28/2001 | CN1285219A Shengxuelongjing medicine for promoting the production of blood |
| 02/28/2001 | CN1285216A Shencaosanye tea |
| 02/28/2001 | CN1285154A Tea with cooling and refreshing function |